Adhesion barrier is a medical implant used in patients with abdominal or pelvic laparotomy as an alternative to the removal of postoperative adhesions between the abdominal wall and the underlying viscera.

Market Dynamics

The adhesion barrier market is expected to expand at a steady growth rate. Significant factors impacting the market growth include rising surgical procedures for small bowel obstruction, infertility and chronic pelvic pain, and cost-effective adhesion prevention. The majority of laparoscopic procedures contribute to adhesions. It is estimated that more than 400,000 laparotomies are conducted annually in the United States for small bowel obstruction. In the United States, obstetricians-gynecologists have been shown to perform two of the most common surgical procedures, involving cesarean delivery and abdominal hysterectomy, which is associated with the risk of developing pelvic adhesions. The study found that adhesions occur in approximately 97% of abdominal interventions that cause chronic pain, infertility, and intestinal obstruction. Moreover, cost-effective prevention of adhesions is also driving the growth of the market. For open surgery, the adhesion barrier lowers the cost of surgery relative to no adhesion barrier, i.e., USD 4.376 versus USD 4.482. A four-year study was conducted in the US, and it was found that the average cost of colorectal surgery had been reduced to USD 106, from USD 4.482 without an adhesion barrier to USD 4.376 with an adhesion barrier.

However, the risk of the use of the adhesion barrier in patients with a history of hypersensitivity and the choice of adhesion barriers among surgeons may hinder the growth of the market.

Segmentation

The global market for adhesion barrier has been segmented into product, formulation, severity, and application. 

Side-effect, the worldwide market for bond hindrance has been portioned into manufactured grip boundaries and normal attachment obstructions. The manufactured attachment obstructions are additionally isolated into hyaluronic corrosive, recovered cellulose, and polyethylene glycol. Manufactured attachment obstructions represented the biggest piece of the pie because of a few benefits over regular bond boundaries, including high biocompatibility, bioresorbable property, and cost-viability of these items. The regular grip obstructions are additionally sectioned into collagen and protein, fibrin.

By detailing, the worldwide bond hindrance has been portioned into film, gel, and fluid. Film based attachment obstructions are projected to hold the biggest portion of the overall industry because of better taking care of qualities and demonstrated positive outcomes. Driving makers for these items are J&J, Sanofi, and others. Gel-based grip obstructions are made out of polyethylene oxide and sodium carboxymethylcellulose, with defensive action. Fluid based grip hindrances are meant to make a site-explicit obstruction on an objective

By severity, the global market for adhesion barrier has been segmented into mild adhesion and severe adhesion. Mild adhesion was the largest market share. According to a study of 122 patients, only three patients were found to have switched from mild to severe adhesion. Example of mild adhesion includes filmy and avascular. Severe adhesion is expected to hold the least market share. Example of severe adhesion includes organized, cohesive, vascular, and dense

By application, the global market for adhesion barrier has been described by gynecological surgeries. Gynecological surgeries are projected to have the largest market share due to a large number of gynecological procedures, and many women are likely to experience post-surgical adhesions. It is estimated that 90 % of patients undergo main abdominal surgery and that between 55% and 100% of females undergo pelvic surgery develop adhesions.

Regional Analysis

Regionally, the global adhesion barrier market has been segmented into the Americas, Europe, the and Asia Pacific.

The Americas drove the grip obstruction market in 2019 and is supposed to keep on ruling the market all through the gauge period. This is because of the presence of an enormous number of clinical gadget firms, an ascent in innovative work, an expansion in laparoscopy methodology, and countless patients. In excess of 400,000 laparotomies are directed every year in the United States alone for little inside obstacle.

Europe is projected to hold the second-biggest offer because of expanded utilization of cutting-edge innovations and expanded item advancement by existing makers.

The Asia Pacific is projected to rise at the highest rate of growth during the study period. This is due to widely populated countries such as China, India, Indonesia, Pakistan, and Bangladesh, growing gynecological procedures, and increasing government initiatives to raise awareness of women's related diseases.

Key Players 

The global adhesion barrier market players are Johnson & Johnson, Atrium Medical Corporation (A Part of Getinge Group), Betatech Medical, R. Bard, FzioMed, Innocoll Holdings, Anika Therapeutics, Integra LifeSciences Holdings Corporation, Baxter International, MAST Biosurgery, Normedi Nordic., Sanofi.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com